Literature DB >> 9035293

Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus.

T Nishimaki1, T Suzuki, Y Tanaka, S Nakagawa, K Aizawa, K Hatakeyama.   

Abstract

To define the rational extent of dissection in radical esophagectomy for esophageal cancer, survival was studied according to nodal status in 154 patients undergoing extended radical esophagectomy. The incidence of cervical metastasis in patients with upper or middle esophageal tumors did not differ between those with favorable (grade N < or = 4) or unfavorable (grade N > or = 5) lymph node status, at 28.6% vs 20%, respectively. On the other hand, in patients with lower esophageal tumors, the incidence of cervical metastasis was significantly lower in those with favorable grade (grade N < or = 4) node status than in those with unfavorable grade (grade N > or = 5) node status, at 6.5% vs 46.7%, respectively. Survival did not differ in patients with upper or middle esophageal tumors according to whether they had regional (n = 42) or distant (n = 15) lymph node metastases, the 5-year survival rates being 11.6% vs 25%, respectively. However, in patients with lower esophageal tumors, none of 10 patients with distant node metastases survived for more than 4 years, whereas the survival rate was 43.7% at 5 years for 36 patients with regional node metastases. These results show that cervical lymphadenectomy should only be performed as part of radical esophagectomy in those patients with upper or middle esophageal cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9035293     DOI: 10.1007/bf01366932

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Lymph node metastasis in thoracic esophageal carcinoma.

Authors:  H Kato; Y Tachimori; H Watanabe; T Iizuka; S Terui; M Itabashi; T Hirota
Journal:  J Surg Oncol       Date:  1991-10       Impact factor: 3.454

2.  Guide lines for the clinical and pathologic studies on carcinoma of the esophagus.

Authors: 
Journal:  Jpn J Surg       Date:  1976-06

3.  Selection of operation for esophageal cancer based on staging.

Authors:  D B Skinner; A G Little; M K Ferguson; A Soriano; V M Staszak
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

4.  Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment.

Authors:  T Nishimaki; O Tanaka; T Suzuki; K Aizawa; H Watanabe; T Muto
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

5.  Better grading systems for evaluating the degree of lymph node invasion in cancer of the thoracic esophagus.

Authors:  T Matsubara; T Kaise; M Ishiguro; T Nakajima
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Evaluation of the new (1987) TNM classification for thoracic esophageal tumors.

Authors:  H Kato; Y Tachimori; H Watanabe; T Iizuka
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

7.  Patterns of lymphatic spread in thoracic esophageal cancer.

Authors:  T Nishimaki; O Tanaka; T Suzuki; K Aizawa; K Hatakeyama; T Muto
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

  7 in total
  7 in total

1.  A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.

Authors:  X Ding; J Zhang; B Li; Z Wang; W Huang; T Zhou; Y Wei; H Li
Journal:  Br J Radiol       Date:  2012-06-14       Impact factor: 3.039

2.  Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus.

Authors:  H Sekiguchi; S Akiyama; M Fujiwara; H Nakamura; K Kondo; Y Kasai; K Ito; J Sakamoto; H Takagi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer.

Authors:  S P Dexter; H Sue-Ling; M J McMahon; P Quirke; N Mapstone; I G Martin
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  A new method (the "Bascule method") for lymphadenectomy along the left recurrent laryngeal nerve during prone esophagectomy for esophageal cancer.

Authors:  Taro Oshikiri; Takashi Yasuda; Hitoshi Harada; Hironobu Goto; Masato Oyama; Hiroshi Hasegawa; Tadayuki Ohara; Hiroyoshi Sendo; Tetsu Nakamura; Yasuhiro Fujino; Masahiro Tominaga; Yoshihiro Kakeji
Journal:  Surg Endosc       Date:  2014-10-11       Impact factor: 4.584

5.  Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes.

Authors:  Koichi Suda; Yoshinori Ishida; Yuichiro Kawamura; Kazuki Inaba; Seiichiro Kanaya; Satoshi Teramukai; Seiji Satoh; Ichiro Uyama
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

6.  Optimized lymph node dissection range during progression of lower thoracic esophageal squamous cell carcinoma in the latest therapeutic surgical strategy: A retrospective analysis.

Authors:  Hiroki Harada; Kei Hosoda; Hiromitsu Moriya; Hiroaki Mieno; Akira Ema; Marie Washio; Yoshimasa Kosaka; Masahiko Watanabe; Keishi Yamashita
Journal:  Oncol Lett       Date:  2018-06-27       Impact factor: 2.967

7.  Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer.

Authors:  Hirokazu Noshiro; Hironori Iwasaki; Kiitiro Kobayashi; Akihiko Uchiyama; Yoshihiro Miyasaka; Toshihiro Masatsugu; Kenta Koike; Kouji Miyazaki
Journal:  Surg Endosc       Date:  2010-05-22       Impact factor: 4.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.